Prasad Devarajan
Pediatric Nephrology · Cincinnati, OHNPI 1235216011
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $95,670 of the $152,430 with a category attached, or 62.8%. Novo Nordisk accounts for 93.4% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $75,247, more than ten times the $3,798 reported in 2020. Among pediatric nephrology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 160 payments — averaging $952.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$142K
- Alnylam Pharmaceuticals Inc.$4K
- Tanabe Pharma America, Inc.$4K
- Beckman Coulter, Inc.$1K
- AstraZeneca$308
- Novo Nordisk Health Care AG$297
- plus $880 from 9 others
Across 4 payments — averaging $2807.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alnylam Pharmaceuticals Inc.$9K
- Novo Nordisk AS$2K
What the payments were for
- Consulting fees$22,27515%
- Speaking & faculty fees$95,67063%
- Travel & lodging$30,26620%
- Food & beverage$4,2193%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 134 | $142,442 |
| Alnylam Pharmaceuticals Inc. | 2 | $3,883 |
| Tanabe Pharma America, Inc. | 5 | $3,620 |
| Beckman Coulter, Inc. | 1 | $1,000 |
| AstraZeneca | 3 | $308 |
| Novo Nordisk Health Care AG | 3 | $297 |
| Travere Therapeutics, Inc. | 3 | $229 |
| Amgen | 2 | $160 |
| Sentynl Therapeutics, Inc. | 1 | $150 |
| Ultragenyx Pharmaceutical Inc. | 1 | $122 |
| GSK | 1 | $105 |
| Novartis | 1 | $38 |
| Vertex | 1 | $35 |
| Apellis Pharmaceuticals, Inc. | 1 | $23 |
| Covidien LP | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$152,430 in reported general payments places this provider in the 90th percentile of 44 pediatric nephrology providers in Ohio.
Other pediatric nephrology in Cincinnati
- Stuart GoldsteinCincinnati$292K
- Francisco FloresCincinnati$156K
- Stefanie BenoitCincinnati$51K
- Hillarey StoneCincinnati$5K
- Meredith HarrisCincinnati$3K
- Elif ErkanCincinnati$224
- Charles VarnellCincinnati$159
- Kyle McCrackenCincinnati$146
- Mark MitsnefesCincinnati$110
- Jean-Philippe RoyCincinnati$50
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.